ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,562Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 11

$450K Total Retail Price of All Prescriptions

Rank: 1 out of 11

351 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

5% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 3,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $70 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
AMLODIPINE BESYLATE 259 190 1 1
FUROSEMIDE 246 194 2 2
CALCITRIOL 198 154 3 4
PREDNISONE 153 74 4 11
LEVOTHYROXINE SODIUM 153 126 4 9
ALLOPURINOL 152 102 6 6
RENVELA 117 60 7 13
LISINOPRIL 116 46 8 3
DOXAZOSIN MESYLATE 114 83 9 13
CARVEDILOL 113 69 10 15
SIMVASTATIN 108 89 11 5
SPIRONOLACTONE 107 79 12 25
HYDROCHLOROTHIAZIDE 99 95 13 19
CALCIUM ACETATE 92 53 14 16
METOPROLOL TARTRATE 91 60 15 10
METOPROLOL SUCCINATE 91 49 15 12
OMEPRAZOLE 88 64 17 8
GABAPENTIN 83 23 18 23
METOLAZONE 79 59 19 34
LOSARTAN POTASSIUM 75 41 20 7
NIFEDIPINE ER 74 45 21 35
LYRICA 67 24 22 39
ATENOLOL 60 32 23 27
HYDROCODONE-ACETAMINOPHEN 59 30 S3 24 22
ZOLPIDEM TARTRATE 59 14 24 41
TAMSULOSIN HCL 57 38 26 42
POTASSIUM CHLORIDE 51 49 27 17
ATORVASTATIN CALCIUM 50 37 28 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.